Inventor

Solomon H. Snyder

Inventor

Baltimore, MD, US

Overview

51→

Patents

1976–2020

Patent span

Human necessities

Primary field (CPC A)

Patents· 51 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes28%

G01NInvestigating or analysing materials by determining their chemical or physical properties16%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations13%

C07KPeptides13%

C12NMicroorganisms or enzymes11%

Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests10%

C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms3%

C07DHeterocyclic compounds2%

Y10TTechnical subjects covered by former us classification2%

C12YEnzymes1%

PatentTitleYear

10,688,096Methods for treatment of sleep-related breathing disorders2020 9,937,144Treatment of drug abuse by preventing GAPDH nitrosylation2018 8,148,095'Methods for predicting psychotropic drugs which elicit weight gain'2012 8,080,367'Regulation of cell survival by HSP90 and IP6K2'2011 7,358,237'Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2'2008 7,001,738'Method for assaying protein nitrosylation'2006 6,806,057'Method for assaying protein nitrosylation'2004 6,774,128'Methods for prevention and treatment of gastrointestinal disorders'2004 6,500,843'Inhibitors of rotamase enzyme activity'2002 6,492,106'Mammalian proteins that bind to FKBP12 in a rapamycin-dependent fashion'2002 6,476,200'Mammalian proteins that bind to FKBP12 in a rapamycin-dependent fashion'2002 6,444,643'Methods of using inhibitors of cyclophilin rotamase activity to affect neurological activity'2002 6,362,160'Immunophilin-binding agents prevent glutamate neurotoxicity associated with vascular stroke and neurodegenerative diseases'2002 6,358,975'Method of using selective parp inhibitors to prevent or treat neurotoxicity'2002 6,168,926'Protein inhibitor of neuronal nitric oxide synthase'2001 6,159,707'Sperm receptors'2000 6,103,872'CAPON: a protein associated with neuronal nitric oxide synthase'2000 6,093,549'Huntingtin-associated protein-related assays'2000 6,080,753'Stimulating nerve growth with immunophilins'2000 6,022,878'Inhibitors of rotamase enzyme activity'2000 RE036397'Inhibitors of poly(ADP-ribose) synthetase and use thereof to treat NMDA neurotoxicity'1999 5,908,756'Protein inhibitor of neuronal nitric oxide synthase'1999 5,898,029'Direct influences on nerve growth of agents that interact with immunophilins in combination with neurotrophic factors'1999 5,846,981'Inhibitors of rotamase enzyme activity'1998 5,843,960'Inhibitors of rotamase enzyme activity'1998 5,798,355'Inhibitors of rotamase enzyme activity'1998 5,696,135'Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth'1997 5,693,756'Amiloride-sensitive sodium channel and method of identifying substances which stimulate or block salty taste perception'1997 5,684,126'Ebnerin: a secreted von Ebner\'s gland protein associated with taste buds'1997 5,587,384'Inhibitors of poly(ADP-ribose) synthetase and use thereof to treat NMDA neurotoxicity'1996 5,525,329'Inhibition of phosphodiesterase in olfactory mucosa'1996 5,439,938'Treatments for male sexual dysfunction'1995 5,380,651'Method of determining odorant compounds and antagonists of odorants using a primary culture of olfactory neurons'1995 5,318,907'Primary culture of olfactory neurons'1994 5,308,763'Method of making primary culture of olfactory neurons'1994 5,268,465'Purification and molecular cloning of nitric oxide synthase'1993 5,266,594'Inhibitors of nitric oxide synthase and use thereof to prevent glutamate neurotoxicity'1993 5,260,270'Odorant-binding protein from rat'1993 5,217,893'Primary culture of olfactory neurons'1993 5,196,315'Human neuronal cell line'1993 5,128,246'Methods for isolating and expressing gene for odorant binding protein'1992 5,030,722'Odorant-binding protein from rat'1991 5,001,056'Preparation of monoclonal antibodies'1991 4,769,377'Adenosine receptor antagonists'1988 4,593,095'Xanthine derivatives'1986 4,520,112'Assay method for organic calcium antagonist drugs and a kit for such an assay'1985 4,311,685'Assay method and kit'1982 4,299,813'Assay kit and method'1981 4,248,853'Assay method and kit'1981 4,197,288'Neuroleptic radioreceptor assay method and kit'1980 3,961,073'Antidepressant'1976

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1976–2020Based in Baltimore, MD, US· patent location history

1980–1982Patents assigned to BURROUGHS WELLCOME CO (2)· patent assignee history

1981–2020Patents assigned to SNYDER SOLOMON H (5)· patent assignee history

1985–2020Patents assigned to UNIV JOHNS HOPKINS (34)· patent assignee history

1997–2002Patents assigned to UNIV JOHNS HOPKINS MED (9)· patent assignee history

1997–2002Patents assigned to GUILFORD PHARM INC (7)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
UNIV JOHNS HOPKINS	34	1985–2020
UNIV JOHNS HOPKINS MED	9	1997–2002
GUILFORD PHARM INC	7	1997–2002
SNYDER SOLOMON Hself	5	1981–2020
BURROUGHS WELLCOME CO	2	1980–1982

Locations

Location	Patents	Span
Baltimore, Maryland, US	51	1976–2020